pharma

Feliz Navidea $29.79M Market Capitalization Navidea Biopharmaceuticals Inc. (NAVB.NYSE) announced today that it has received regulatory approval in India for its Lymphoaim, also referred to as Lymphoseek in the…
In this episode, we look at BetterLife Sciences (BETR.C), an emerging biotech company focused on the development and commercialization of cutting-edge treatments for mental disorders. We check out their…
Nextleaf Solutions (OILS.C) received a patent for the prodrug producing, acetylation of cannabinoids today from the Canadian Intellectual Property Office, according to a press release. Specifically, the patent is…
“With more than 8 years of proven in-market safety internationally and a robust supply chain ensuring product availability, we expect Redesca to play a major role in the achievement…
“There is a strong scientific and medical rationale for the use of Hesperco capsules to support the immune system,” stated Pierre Laurin, CEO of Ingenew, who added that it…
Doing what we do at Equity Guru, every day, we receive emails and dms from shareholders of different companies – all expressing their grievances. Disgruntled with various issues such…
If you’re one of the discerning readers who bought Valeo Pharma’s stock since the last article I posted on July 6th, 2020: congratulations you should be making over 38%…
“Spectrum Therapeutics’ medical patients can have confidence that their legal cannabis purchases will arrive at their door in a safe and timely fashion,” stated Rosy Mondin, CEO of World-Class…
I love it when a plan comes together. Predictmedix (PMED.C) continued to launch itself upward this week, jumping from $0.72 to $0.98 in just days, on the back of…
March, 2020 PED revenues increased 265% from those in January, 2020 – as the company’s operations ramp up to satisfy growing demand….